Telehealth geriatric assessment significantly improves short-term outcomes for older adults with advanced cancers … JAMA releases feeding guide for advanced dementia patients and families … Heart ...

Caregivers, medical professionals and family members predict serious consequences for seniors suffering severe neurological ...

A support group for people with Alzheimer’s, their families and caregivers is inviting the public to join them for a walk ...

The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and ...

Higher levels of well-being may help reduce the risk of memory loss in middle age, suggests new research, which tracked more ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s ...

The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ...

Drugs to treat Alzheimer's disease have been rejected for use on the NHS by the health spending watchdog. The National Institute for Health and Care Excellence (NICE) has said the benefits of ...

Higher levels of wellbeing may help reduce the risk of memory loss in middle age, suggests new research, which tracked more than 10,000 over ...

THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. | ITV National News ...